MT
Showing 1 - 25 of 7,056
Developmental Dyslexia Trial in Roma (Active HD-tDCS over V5/MT, Active HD-tDCS over V1, Sham HD-tDCS over V5/MT or V1)
Recruiting
- Developmental Dyslexia
- Active HD-tDCS over V5/MT
- +2 more
-
Roma, ItalyBambino Gesù Hospital and Research Institute
Aug 2, 2023
Stroke, Cerebrovascular Disorders, CNS Diseases Trial in Taoyuan City (Virtual Reality-based Mirror Therapy (VR+MT), Mixed
Not yet recruiting
- Stroke
- +2 more
- Virtual Reality-based Mirror Therapy (VR+MT)
- +2 more
-
Taoyuan City, TaiwanTaoyuan Chang Gung Memorial Hospital
Jun 6, 2023
Epithelial Tumors, Malignant Trial in Randwick (MT-302 (A))
Recruiting
- Epithelial Tumors, Malignant
- MT-302 (A)
-
Randwick, New South Wales, AustraliaScientia Clinical Research Ltd
Aug 1, 2023
Healthy Adult Males Trial in Shinjuku-ku (MT-3921, Placebo)
Completed
- Healthy Adult Males
- MT-3921
- Placebo
-
Shinjuku-ku, Tokyo, JapanClinical Research Hospital Tokyo
Jan 16, 2023
Healthy Trial in Beijing (MT200605 for Injection, MT200605 Placebo)
Enrolling by invitation
- Healthy
- MT200605 for Injection
- MT200605 Placebo
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Jul 13, 2023
Respiratory Viral Infection Trial (SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1)
Not yet recruiting
- Respiratory Viral Infection
- SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
- BioFire Respiratory Panel 2.1
- (no location specified)
Jul 13, 2023
Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule
Recruiting
- Drug-Induced Liver Injury
- +2 more
- MT2004 Capsule
- MT2004 Capsule Placebo
-
Shanghai, Shanghai, ChinaShanghai Jiaotong University School of Medicine,Renji Hospital
Aug 25, 2023
ICAS - Intracranial Atherosclerosis Trial (Stenting plus medical therapy, Medical therapy alone)
Not yet recruiting
- ICAS - Intracranial Atherosclerosis
- Stenting plus medical therapy
- Medical therapy alone
- (no location specified)
Aug 1, 2023
Depression, Anxiety Trial in Shenzhen (MT Combined With XKSA, MT)
Completed
- Depression, Anxiety
- MT Combined With XKSA
- MT
-
Shenzhen, ChinaShenzhen Hospital of Integrated Traditional Chinese and Western
Nov 29, 2022
Erythropoietic Protoporphyria (EPP) Trial in United States (MT-7117 low dose, MT-7117 high dose, Placebo)
Completed
- Erythropoietic Protoporphyria (EPP)
- MT-7117 low dose
- +2 more
-
Los Angeles, California
- +8 more
Dec 22, 2022
Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)
Recruiting
- Lymphoma, T-Cell, Peripheral
- +4 more
- MT-101
- MT-101 + Conditioning (Lymphodepleting) Chemotherapy
-
Duarte, California
- +8 more
Jan 27, 2023
Non-specific Chronic Low Back Pain Trial in Thessaloníki (MT+ PNE with MI, MT, Control)
Active, not recruiting
- Non-specific Chronic Low Back Pain
- MT+ PNE with MI
- +2 more
-
Thessaloníki, Sindos Thessaloníki, Greece, GreeceDepartment of Physiotherapy, Faculty of Health Sciences Internat
Jun 23, 2023
Acute Coronary Syndrome Trial in Muncie (MT1002 for Injection)
Recruiting
- Acute Coronary Syndrome
- MT1002 for Injection
-
Muncie, IndianaBruce Graham
Jan 23, 2023
Stroke Trial in Hong Kong (Transcutaneous electrical nerve stimulation (TENS), Mirror Therapy (MT), sham-Mirror Therapy
Recruiting
- Stroke
- Transcutaneous electrical nerve stimulation (TENS)
- +3 more
-
Hong Kong, Hong KongThe Hong Kong Polytechnic University
Aug 2, 2022
Parkinson's Disease Trial in Secaucus (MT101-5)
Completed
- Parkinson's Disease
-
Secaucus, New JerseyFrontage Clinical Services, 1nc.
Apr 25, 2023
Mt-sDNA asSurveillance Procedure in Colorectal Cancer Survivors
Not yet recruiting
- Adenocarcinoma of the Colon
- +4 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 30, 2023
SARS-CoV-2 Infection Trial in Osaka-shi, Suita-shi, Shinjuku-ku (MT-2766 High dose, Placebo, MT-2766 Low dose)
Active, not recruiting
- SARS-CoV-2 Infection
- MT-2766 High dose
- +2 more
-
Osaka-shi, Osaka, Japan
- +2 more
Mar 25, 2022
Transcranial Direct Current Stimulation (tDCS), Transcranial Random Noise Stimulation (tRNS) Trial (tRNS, tDCS, sham
Not yet recruiting
- Transcranial Direct Current Stimulation (tDCS)
- Transcranial Random Noise Stimulation (tRNS)
- tRNS
- +3 more
- (no location specified)
Feb 8, 2023